CS250683B2 - Method of s-(-)-3-(3-acetyl-4/3-tertiary butylamino-2-hydroxypropoxy/phenyl)-1,1-diethylurea production - Google Patents

Method of s-(-)-3-(3-acetyl-4/3-tertiary butylamino-2-hydroxypropoxy/phenyl)-1,1-diethylurea production Download PDF

Info

Publication number
CS250683B2
CS250683B2 CS851926A CS192685A CS250683B2 CS 250683 B2 CS250683 B2 CS 250683B2 CS 851926 A CS851926 A CS 851926A CS 192685 A CS192685 A CS 192685A CS 250683 B2 CS250683 B2 CS 250683B2
Authority
CS
Czechoslovakia
Prior art keywords
salt
phenyl
acid
acetyl
enantiomer
Prior art date
Application number
CS851926A
Other languages
Czech (cs)
English (en)
Inventor
Gerhard Zoelss
Richard Gratz
Karl Schloegl
Otmar Hofer
Robert J Gordon
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of CS250683B2 publication Critical patent/CS250683B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Epoxy Compounds (AREA)
CS851926A 1984-03-21 1985-03-19 Method of s-(-)-3-(3-acetyl-4/3-tertiary butylamino-2-hydroxypropoxy/phenyl)-1,1-diethylurea production CS250683B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843410380 DE3410380A1 (de) 1984-03-21 1984-03-21 S(-)-celiprolol, dessen pharmazeutisch vertraegliche salze, verfahren zu dessen herstellung, verwendung in der therapie und pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
CS250683B2 true CS250683B2 (en) 1987-05-14

Family

ID=6231193

Family Applications (2)

Application Number Title Priority Date Filing Date
CS851925A CS250682B2 (en) 1984-03-21 1985-03-19 Method of s(-)-3-(3-acetyl-4-/3-tertiary butylamino-2-hydroxypropoxy/-phenyl)-1,1-diethylurea production
CS851926A CS250683B2 (en) 1984-03-21 1985-03-19 Method of s-(-)-3-(3-acetyl-4/3-tertiary butylamino-2-hydroxypropoxy/phenyl)-1,1-diethylurea production

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS851925A CS250682B2 (en) 1984-03-21 1985-03-19 Method of s(-)-3-(3-acetyl-4-/3-tertiary butylamino-2-hydroxypropoxy/-phenyl)-1,1-diethylurea production

Country Status (21)

Country Link
EP (1) EP0155518B1 (fr)
JP (1) JPS60209557A (fr)
AT (1) ATE45945T1 (fr)
AU (1) AU567797B2 (fr)
CA (1) CA1236116A (fr)
CS (2) CS250682B2 (fr)
DD (2) DD234860A1 (fr)
DE (2) DE3410380A1 (fr)
DK (1) DK124585A (fr)
ES (1) ES541424A0 (fr)
FI (1) FI83636C (fr)
GR (1) GR850496B (fr)
HU (1) HU193596B (fr)
IL (1) IL74383A (fr)
NO (1) NO161254C (fr)
PL (2) PL143883B1 (fr)
PT (1) PT80135B (fr)
RO (2) RO91353B (fr)
SU (2) SU1333235A3 (fr)
YU (2) YU45707B (fr)
ZA (1) ZA852086B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
AT388099B (de) * 1986-11-26 1989-04-25 Chemie Holding Ag Verfahren zur hestellung von festen arzneiformen von (3-(3-acetyl-4-(3-tert. butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylharnstoff)- hydrochlorid
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
EP0423484B1 (fr) * 1989-10-16 1993-11-03 PCD-Polymere Gesellschaft m.b.H. Comprimé à libération retardée
DE3935736A1 (de) * 1989-10-27 1991-05-02 Chemie Linz Deutschland Pressling mit retardierter wirkstofffreisetzung
US5227526A (en) * 1992-06-16 1993-07-13 Mallinckrodt Specialty Chemicals Company Resolution of 3-dimethylamino-2-methylpropiophenone (3-DAMP)
CN101239937B (zh) * 2007-02-07 2010-05-19 上海雅本化学有限公司 一种光学活性r-(-)-1-苄氧羰基-3-氨基吡咯烷及其盐酸盐的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT334385B (de) * 1973-12-20 1976-01-10 Chemie Linz Ag Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
HU170678B (fr) * 1973-12-20 1977-08-28
HU170677B (fr) * 1973-12-21 1977-08-28
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma

Also Published As

Publication number Publication date
DK124585D0 (da) 1985-03-20
SU1309908A3 (ru) 1987-05-07
PL252462A1 (en) 1985-11-19
IL74383A (en) 1988-09-30
RO91353A (fr) 1987-04-30
PL252463A1 (en) 1985-11-19
YU44485A (en) 1987-06-30
HU193596B (en) 1987-11-30
AU3972285A (en) 1985-09-26
YU44385A (en) 1987-06-30
NO161254C (no) 1989-07-26
PL143883B1 (en) 1988-03-31
IL74383A0 (en) 1985-05-31
CA1236116A (fr) 1988-05-03
ATE45945T1 (de) 1989-09-15
YU45246B (en) 1992-05-28
SU1333235A3 (ru) 1987-08-23
FI850860A0 (fi) 1985-03-04
GR850496B (fr) 1985-03-15
PT80135B (pt) 1987-10-20
DE3410380A1 (de) 1985-10-10
JPS60209557A (ja) 1985-10-22
FI83636C (fi) 1991-08-12
EP0155518B1 (fr) 1989-08-30
DD234860A1 (de) 1986-04-16
DE3572656D1 (en) 1989-10-05
AU567797B2 (en) 1987-12-03
NO850834L (no) 1985-09-23
EP0155518A3 (en) 1986-06-25
RO91353B (ro) 1987-05-01
NO161254B (no) 1989-04-17
FI850860L (fi) 1985-09-22
FI83636B (fi) 1991-04-30
RO91352A (fr) 1987-04-30
RO91352B (ro) 1987-05-02
ZA852086B (en) 1985-11-27
YU45707B (sh) 1992-07-20
ES8603390A1 (es) 1985-12-16
CS250682B2 (en) 1987-05-14
EP0155518A2 (fr) 1985-09-25
HUT37392A (en) 1985-12-28
PT80135A (de) 1985-04-01
DD232489A1 (de) 1986-01-29
DK124585A (da) 1985-09-22
ES541424A0 (es) 1985-12-16

Similar Documents

Publication Publication Date Title
NO146432B (no) Analogifremgangsmaate ved fremstilling av et dihydrokarbostyrilderivat
JPH0428269B2 (fr)
EP0112191A1 (fr) Nouveaux dérivés du 4-(1H-indol-3-yl) alpha-méthylpipéridine 1-éthanol, leurs sels, le procédé de préparation, l'application à titre de médicaments et les compositions les renfermant
CS250683B2 (en) Method of s-(-)-3-(3-acetyl-4/3-tertiary butylamino-2-hydroxypropoxy/phenyl)-1,1-diethylurea production
IE920046A1 (en) N-hydroxyurea derivatives as antiallergy and¹antiinflammatory agents
JPH02180A (ja) ２，２‐ジメチルクロメン誘導体、その製造方法及びこれを含む薬剤組成物
HU176707B (en) Process for producing 14,15-dihydro-20,21-dinor-eburnamenine-14-ol-isomeres
JP2002532470A (ja) パロキセチンマレイン酸塩の製法
CA1229348A (fr) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane, agent therapeutique
EP0053434B1 (fr) Composés et procédé pour le traitement ou la prophylaxie de maladies cardiaques
JPH0676373B2 (ja) グアニジノ安息香酸エステル誘導体
JPH033671B2 (fr)
JPH08511008A (ja) 複素環式化学
JPS61158980A (ja) ８α‐アシルアミノエルゴリン類、その製法および医薬組成物
PL117485B1 (en) Process for manufacturing novel derivatives of n-substituted 3-phenylopropylaminefenilpropilamina
CA1147331A (fr) 10-bromosandwicine, 10-bromoisosandwicine, methode de preparation, applications et composes pharmaceutiques les contenant
FR2599033A1 (fr) Derives des 3-(hydroxymethyl)-isoquinoleine, procede pour les preparer et compositions pharmaceutiques les contenant
US4338320A (en) Esters of 6'-hydroxycinchonine, and a method of treating arrythmia with them
JPH02258749A (ja) ポリヒドロキシベンジルオキシプロパノールアミン
JP5858298B2 (ja) ヘキセノン化合物及びその医学的使用
JPS6330902B2 (fr)
HU215387B (hu) Vizelet-visszatartási képtelenség kezelésére alkalmas kinolonszármazék, eljárás előállítására, és a vegyület alkalmazása gyógyszerkészítmények előállítására
HU188342B (en) Process for preparing new dihydropyridine derivatives
JPS63188664A (ja) 新規なｎ−（１ｈ−インドール−４−イル）ベンズアミド誘導体及びそれらの塩、薬剤としての使用並びにそれらを含有する組成物
JPH0348193B2 (fr)